找回密碼
 To register

QQ登錄

只需一步,快速開(kāi)始

掃一掃,訪問(wèn)微社區(qū)

打印 上一主題 下一主題

Titlebook: Global Pharmaceutical Policy; Zaheer-Ud-Din Babar Book 2020 The Editor(s) (if applicable) and The Author(s) 2020 Pharmaceutical policy.cou

[復(fù)制鏈接]
樓主: dilate
31#
發(fā)表于 2025-3-27 00:40:53 | 只看該作者
32#
發(fā)表于 2025-3-27 04:20:36 | 只看該作者
33#
發(fā)表于 2025-3-27 07:17:04 | 只看該作者
978-981-15-2726-5The Editor(s) (if applicable) and The Author(s) 2020
34#
發(fā)表于 2025-3-27 12:45:04 | 只看該作者
https://doi.org/10.1007/978-981-15-2724-1Pharmaceutical policy; counterfeit medicines; medicines promotion; generic medicines; pharmacy health se
35#
發(fā)表于 2025-3-27 15:25:26 | 只看該作者
Zaheer-Ud-Din BabarThe only text available today which provides an up to date account of international pharmaceutical policy research.Analyses the most relevant areas that may impact on the quality use of medicines and
36#
發(fā)表于 2025-3-27 18:16:00 | 只看該作者
Medicines Safety in the Globalized Context, pharmacovigilance system is important in the current global scenario and how it improves patient health. The chapter describes a summary of best practices related to medicines safety. There are examples of pharmacovigilance from America,?Canada, New Zealand and other?developed and developing countr
37#
發(fā)表于 2025-3-28 01:51:25 | 只看該作者
,Managing the Pharmaceutical Supply Chain—To Sustainability and Beyond,harmaceutical supply chain, sustainability can mean business survival; addressing resource depletion; manufacturing in a conscientious and responsible manner; contributing to our economy and doing no harm to our society and communities. To act sustainably is a challenge in a supply chain which conti
38#
發(fā)表于 2025-3-28 05:30:23 | 只看該作者
39#
發(fā)表于 2025-3-28 07:38:51 | 只看該作者
Global Access to Cancer Medicines,ries. When comparing it by global economic levels, the Global North shows relatively low mortality rate due to screening, early detection and development and availability of treatment therapy. Recently, anticancer drugs are becoming more expensive. However, it is questionable whether the high cost i
40#
發(fā)表于 2025-3-28 11:18:08 | 只看該作者
 關(guān)于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務(wù)流程 影響因子官網(wǎng) 吾愛(ài)論文網(wǎng) 大講堂 北京大學(xué) Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點(diǎn)評(píng) 投稿經(jīng)驗(yàn)總結(jié) SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學(xué) Yale Uni. Stanford Uni.
QQ|Archiver|手機(jī)版|小黑屋| 派博傳思國(guó)際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-7 11:04
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved
快速回復(fù) 返回頂部 返回列表
崇礼县| 咸阳市| 改则县| 阿拉善左旗| 甘南县| 会泽县| 项城市| 青神县| 青河县| 阳信县| 禹城市| 凤台县| 绥滨县| 怀来县| 六盘水市| 龙岩市| 张家港市| 庆云县| 和静县| 于都县| 常州市| 伊宁市| 安福县| 贵德县| 淄博市| 永和县| 普格县| 扎鲁特旗| 隆昌县| 绍兴市| 子洲县| 衡水市| 丹寨县| 婺源县| 大埔县| 巍山| 仪征市| 安远县| 桐城市| 嘉善县| 新干县|